Song N, Tan Y, Zhang L, Luo W, Guan Q, Yan M, et al. Detection of circulating Mycobacterium tuberculosis-specific DNA by droplet digital PCR for vaccine evaluation in challenged monkeys and TB diagnosis. Emerg Microbes Infect. 2018;7:78 pubmed publisher

Wentink M, Verheul H, Griffioen A, Schafer K, McPherson S, Early R, et al. A safety and immunogenicity study of immunization with hVEGF26-104/RFASE in cynomolgus monkeys. Vaccine. 2018;36:2025-2032 pubmed publisher

Sharpe S, Smyth D, McIntyre A, Gleeson F, Dennis M. Refinement and reduction through application of a quantitative score system for estimation of TB-induced disease burden using computed tomography. Lab Anim. 2018;52:599-610 pubmed publisher

Cirac A, Stützle S, Dieckmeyer M, Adhikary D, Moosmann A, Körber N, et al. Epstein-Barr virus strain heterogeneity impairs human T-cell immunity. Cancer Immunol Immunother. 2018;67:663-674 pubmed publisher

Sauermann U, Radaelli A, Stolte Leeb N, Raue K, Bissa M, Zanotto C, et al. Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4+ and CD8+ T-Cell Responses. J Virol. 2017;91: pubmed publisher

Ellis A, Balgeman A, Rodgers M, Updike C, Tomko J, Maiello P, et al. Characterization of T Cells Specific for CFP-10 and ESAT-6 in Mycobacterium tuberculosis-Infected Mauritian Cynomolgus Macaques. Infect Immun. 2017;85: pubmed publisher

Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed publisher

Currier J, Kuta E, Turk E, Earhart L, Loomis Price L, Janetzki S, et al. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods. 2002;260:157-72 pubmed